Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Volitionrx Ltd as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q4 2024
- Shares held
- 21.0M
- +2.32M (+12.4%) vs. Q4 2024
- Total value
- $12.0M
- +$765.0K (+6.8%) vs. Q4 2024
- New holders
- 4
- 8 more added
- Sold out
- 6
- 6 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 10,194,000 | $5.81M | 3.70% | +2,618,000+34.6% | Added |
| Armistice Capital, LLC | 8,206,430 | $4.68M | 0.13% | −275,465−3.2% | Reduced |
| Geode Capital Management, LLC | 761,951 | $434.5K | 0.00% | +18,108+2.4% | Added |
| Vanguard Group Inc | 706,060 | $402.5K | 0.00% | +69,393+10.9% | Added |
| BlackRock, Inc. | 445,187 | $253.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 147,638 | $84.2K | 0.00% | 00.0% | Unchanged |
| Silverberg Bernstein Capital Management LLC | 140,573 | $80.1K | 0.07% | +6,660+5.0% | Added |
| Northern Trust Corp | 117,875 | $67.2K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 83,178 | $47.4K | 0.00% | −24,171−22.5% | Reduced |
| Squarepoint Ops LLC | 60,809 | $34.7K | 0.00% | +60,809 | New |
| XTX Topco Ltd | 32,270 | $18.4K | 0.00% | +10,911+51.1% | Added |
| Bank of New York Mellon Corp | 30,596 | $17.4K | 0.00% | +30,596 | New |
| Two Sigma Securities, LLC | 21,482 | $12.2K | 0.00% | −27,428−56.1% | Reduced |
| Chicago Partners Investment Group LLC | 17,713 | $9.20K | 0.00% | +17,713 | New |
| Tower Research Capital LLC (TRC) | 12,663 | $7.22K | 0.00% | +4,084+47.6% | Added |
| Millennium Management LLC | 10,818 | $6.17K | 0.00% | −49,820−82.2% | Reduced |
| Creative Planning | 10,056 | $5.73K | 0.00% | −13,155−56.7% | Reduced |
| Hartford Financial Management Inc. | 5,000 | $2.85K | 0.00% | 00.0% | Unchanged |
| Founders Capital Management | 2,000 | $1.14K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 900 | $513 | 0.00% | −10,000−91.7% | Reduced |
| Bank of America Corp | 619 | $353 | 0.00% | +31+5.3% | Added |
| FMR LLC | 300 | $171 | 0.00% | +300 | New |
| BNP Paribas Arbitrage, SA | 265 | $151 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 200 | $98 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 534 | $0 | 0.00% | +157+41.6% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −68,192−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −20,280−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,248−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,324−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,481−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −10−100.0% | Sold out |